ANGELICA PETROUS: Open Payments
NPI 1265034623 · CLINTON, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,427 in 38 payments from 16 companies in 2025. Trend: 2023 $584 · 2024 $218 · 2025 $1,427
Food & beverage: $759Education: $468Long term medical supply or device loan: $199
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $238 |
| Novartis Pharmaceuticals Corporation | 3 | $228 |
| Astellas Pharma US Inc | 3 | $195 |
| Daiichi Sankyo Inc. | 4 | $178 |
| Incyte Corporation | 3 | $137 |
| Merck Sharp & Dohme LLC | 3 | $64 |
| ABBVIE INC. | 2 | $60 |
| PFIZER INC. | 2 | $59 |
| TerSera Therapeutics LLC | 2 | $53 |
| Sumitomo Pharma America, Inc. | 2 | $43 |
Products named: KISQALI, Enhertu, RYBREVANT, ERLEADA, KEYTRUDA, ELAHERE, Zoladex, ORGOVYX.
Industry payments across MD — which companies pay providers there.
